Literature DB >> 6277787

Pathogenesis of Herpes simplex virus infections in guinea pigs.

M Scriba, F Tatzber.   

Abstract

The pathogenesis of herpes simplex virus types 1 and 2 has been studied in guinea pigs after inoculation by various routes (subcutaneous and intradermal infection in footpads and vaginal infection). Clinical observations as well as virus isolation studies are reported. Herpes simplex virus type 2 infection by all three routes of inoculation led to acute primary and recurrent lesions. Virus persisted in the nervous system, particularly in sensory ganglia, and locally at the site of inoculation. Herpes simplex virus type 1 infection induced no or very mild primary symptoms. Recurrent lesions were only observed after intradermal inoculation. Invasion of the nervous system and consequent establishment of latent ganglionic infection was less efficient than after herpes simplex virus type 2 infection. Peripheral persistence was, however, equally common.

Entities:  

Mesh:

Year:  1981        PMID: 6277787      PMCID: PMC350922          DOI: 10.1128/iai.34.3.655-661.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Herpes simplex virus infection in guinea pigs: an animal model for studying latent and recurrent herpes simplex virus infection.

Authors:  M Scriba
Journal:  Infect Immun       Date:  1975-07       Impact factor: 3.441

2.  Genetics of natural resistance to herpesvirus infections in mice.

Authors:  C Lopez
Journal:  Nature       Date:  1975-11-13       Impact factor: 49.962

3.  Latent ganglionic infection with herpes simplex virus types 1 and 2: viral reactivation in vivo after neurectomy.

Authors:  M A Walz; R W Price; A L Notkins
Journal:  Science       Date:  1974-06-14       Impact factor: 47.728

4.  Guinea pig model for cutaneous herpes simplex virus infection.

Authors:  W R Hubler; T D Felber; D Troll; M Jarratt
Journal:  J Invest Dermatol       Date:  1974-02       Impact factor: 8.551

5.  Latent herpes simplex virus. Isolation from rabbit trigeminal ganglia between episodes of recurrent ocular infection.

Authors:  A B Nesburn; M L Cook; J G Stevens
Journal:  Arch Ophthalmol       Date:  1972-10

6.  Latent herpes simplex virus from trigeminal ganglia of rabbits with recurrent eye infection.

Authors:  J G Stevens; A B Nesburn; M L Cook
Journal:  Nat New Biol       Date:  1972-02-16

7.  Latent herpes simplex virus in spinal ganglia of mice.

Authors:  J G Stevens; M L Cook
Journal:  Science       Date:  1971-08-27       Impact factor: 47.728

8.  Crossed immunoelectrophoretic characterization of Herpesvirus hominis type 1 and 2 antigens.

Authors:  B F Vestergaard
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1973-12

9.  Investigation of plaque formation in chick embryo cells as a biological marker for distinguishing herpes virus type 2 from type 1.

Authors:  S P Lowry; J L Melnick; W E Rawls
Journal:  J Gen Virol       Date:  1971-01       Impact factor: 3.891

10.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

View more
  12 in total

1.  Hamster model for herpes simplex virus infection of the central nervous system.

Authors:  L T van Ekdom; P Herbrink; M J Meddens
Journal:  Infection       Date:  1987 Mar-Apr       Impact factor: 3.553

2.  Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.

Authors:  R F Schinazi; R T Scott; J Peters; V Rice; A J Nahmias
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

Review 3.  The pathogenesis of acute, latent and recurrent herpes simplex virus infections.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Dissemination of herpes simplex virus in ganglia after footpad inoculation in neurectomized and non-neurectomized mice.

Authors:  R J Klein; E DeStefano
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

Review 5.  Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

Authors:  Gargi Dasgupta; Lbachir BenMohamed
Journal:  Vaccine       Date:  2011-06-28       Impact factor: 3.641

Review 6.  DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward.

Authors:  Nicholas D Weber; Martine Aubert; Chung H Dang; Daniel Stone; Keith R Jerome
Journal:  Virology       Date:  2014-01-31       Impact factor: 3.616

7.  Herpes simplex virus type 1 persistence and latency in cultured rabbit corneal epithelial cells, keratocytes, and endothelial cells.

Authors:  S D Cook; S M Brown
Journal:  Br J Ophthalmol       Date:  1986-09       Impact factor: 4.638

8.  Animal studies on the efficacy of vaccination against recurrent herpes.

Authors:  M Scriba
Journal:  Med Microbiol Immunol       Date:  1982       Impact factor: 3.402

9.  Neurovirulence of individual plaque stocks of Herpes simplex virus type 2 strain HG 52.

Authors:  M Y Taha; S M Brown; G B Clements
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

10.  Enhanced in vitro reactivation of latent herpes simplex virus from neural and peripheral tissues with hexamethylenebisacetamide.

Authors:  D I Bernstein; J C Kappes
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.